drugset / Trial / NCT00053040
Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of immunotoxin therapy and to see how well it works in treating children undergoing surgery for recurrent or progressive malignant glioma.
Timeline
- Start
- 2005-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cintredekin besudotox | Protein / enzyme biologic | 0.25 ug/ml | Other |